Excerpts from DBS Vickers report

Analyst: Andy SIM, CFA

DrBengTeckLiang8.16bDr Beng Teck Liang, CEO, Singapore Medical Group. NextInsight file photoRobust growth prognosis
♦ Initiate coverage with BUY and TP of S$0.75 on the back 
of continued robust growth post a successful turnaround

♦ Project net profit growth of 292%/32% on ramp-up in diagnostics, recent acquisitions, and margin improvements

♦ Further re-rating catalysts to come from acquisitions, better operating performance and overseas ventures

♦ TP based on 25x FY18F/19F PE

 

S'pore Medical Grp

Share price:
60c

Target: 
75c

Initiate with BUY and TP of S$0.75. We initiate coverage on Singapore Medical Group (SMG) with a BUY call and TP of S$0.75, implying 25% upside. We believe the group's continued robust earnings growth following the successful turnaround of its operations since FY16, will provide a re-rating catalyst for the counter.

We are projecting core earnings growth of 292%/32% in 
FY17F/18F on the back of (i) further scaling up of its Diagnostics business; (ii) recent acquisitions; and (iii) margin expansion from larger scale of operations.


Growing network.
SMG is a private specialist and primary 
healthcare provider with a network of more than 20 medical specialties, based primarily in Singapore. Post its business review in 2013 and the appointment of its current CEO, Dr Beng Teck Liang, SMG has embarked on several acquisitions and operational initiatives and has successfully turned around, posting profit in FY16.

AndySim10.14Valuation:
Our TP of S$0.75 is based on 25x FY17F/18F PE. This implies a PEG of c.0.3x based on earnings CAGR (FY16-FY19F) of 80% given the robust growth projections. 

-- Andy Sim, CFA (photo)
Analyst, DBS Vickers

The number of doctors in the group has grown from 26 in 2015 to more than 30 currently, and we project this to increase further to over 40 through its recruitment efforts and attractiveness given its growing size.

In addition, its diagnostics 
business has continued to reap rewards post its successful turnaround, and has a new expanded 5,500-sqft facility in Novena. Its overseas ventures in Vietnam and Indonesia could also add to its medium-term growth catalyst.

Key Risks to Our View:

Lower-than-expected profitability from acquisitions, departure of key doctors, inability to ramp up operations are threats to growth thesis.

Full report here. 


Share Prices

Counter NameLastChange
AEM Holdings6.730-0.260
Alliance Mineral0.3650.005
AusGroup0.0500.001
Avi-Tech Electronics0.480-0.005
Best World Int.1.580-0.010
China Sunsine1.5100.050
DISA Limited0.010-
Dutech Holdings0.2700.020
Federal Int. (2000)0.3550.005
Food Empire0.660-0.005
Geo Energy0.230-
Golden Energy0.370-0.005
GSS Energy0.159-0.001
Heeton Holdings0.570-
ISOTeam0.365-
KSH Holdings0.665-0.010
Lian Beng Group0.625-0.010
Miyoshi0.071-
Nordic Group0.550-0.015
Oxley Holdings0.485-0.010
REX International0.0520.001
Riverstone1.080-0.010
Roxy-Pacific0.535-0.005
Serial System0.171-
Sing Holdings0.440-0.005
Sino Grandness0.197-
Straco Corp.0.810-
Sunningdale Tech1.720-0.010
Sunpower Group0.480-0.005
The Trendlines0.122-0.002
Tiong Seng0.390-0.005
Trek 2000 Int.0.230-0.010
Uni-Asia Group1.4300.020
XMH Holdings0.300-
Yangzijiang Shipbldg1.210-0.030

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 2529 guests and no members online